Christopher Ohl to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Christopher Ohl has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.050
-
Morris PE, Hite RD, Ohl C. Relationship between the inflammation and coagulation pathways in patients with severe sepsis: implications for therapy with activated protein C. BioDrugs. 2002; 16(6):403-17.
Score: 0.050